How Studying Down Syndrome May Help Alzheimer’s Research
A new multi-omics dataset from a unique cohort of adults with Down Syndrome is helping researchers understand Alzheimer's Disease By Zoë Leanza Researchers have shared complex biological data through the AD Knowledge Portal to advance studies of [...]
Antibody Characterization for the Community
TREAT-AD is partnering with YCharOS to provide antibody characterization for understudied AD targets By Zoë Leanza To de-risk understudied therapeutic targets, the TREAT-AD research center is partnering with YCharOS, a new organization seeking to identify high-quality antibodies [...]
AMP-AD 2.0
NIH invests in next iteration of public-private partnership to advance precision medicine research for Alzheimer’s disease The National Institutes of Health has launched the next version of the Accelerating Medicines Partnership (AMP) Alzheimer’s disease program (AMP AD 2.0) [...]
Somatic Mosaicism and Alzheimer’s Disease Risk
SMIB-AD Study: a Community Data Contribution By Zoë Leanza Earlier this year, Dr. Chunyu Liu’s team shared data from the Somatic Mutations in Brains of Alzheimer's Disease (SMIB-AD) study through the AD Knowledge Portal’s newly established Community [...]